• Philipp Schindler, Hans-Gerd Kehl, Moritz Wildgruber, Walter Heindel, and Christoph Schülke.
• Institute of Clinical Radiology, University Hospital Muenster, Albert-Schweitzer-Campus 1, D-48149 Muenster, Germany. Electronic address: Philipp.Schindler@ukmuenster.de.
• Acad Radiol. 2020 May 1; 27 (5): e102-e108.

Rationale And ObjectivesCongenital heart diseases (CHD) belong to the leading causes of infant mortality worldwide. Prognostic improvements result from multimodal therapy strategies leading to an increased demand for noninvasive imaging. The aim of the study was to further optimize cardiac CT radiation dose by omitting the test bolus or bolus tracking scan, which can have a relevant share of radiation exposure, especially in neonates.Materials And MethodsThis retrospective study included 25 neonates with CHD who received a CT angiography (CTA) from 2009 to 2018. The examinations were performed as a high-pitch CTA (pitch 3.4, 80 kV) with manual contrast administration (1.5 ml/kg body weight) and fixed scan delay depending on the respective heart defect. Diagnosis, adverse events, radiation dose parameters, objective (contrast-to-noise ratio) and subjective (4-point Likert scale) image quality as well as diagnostic accuracy compared to intraoperative findings was assessed.ResultsAll examinations were diagnostically evaluable without adverse events. The median CT dose index volume (CTDIvol) was 0.50 mGy (range, 0.15-0.94), the median dose-length product was 8 mGy × cm (range, 3-17). The estimation of the effective dose by Monte Carlo simulation revealed lower median dose levels 0.66 mSv (range, 0.25-1.40 mSv) than previously published in comparable groups. All examinations achieved a very good mean image quality score of 1.2 ± 0.4 with only minimal image noise and mean contrast-to-noise ratio of 16.1 ± 7.0. Diagnostic accuracy was 100 % as cardiac anatomy revealed no new diagnoses or significant differences in the subsequent cardiac surgery.ConclusionCardiac high-pitch CTA of neonates with CHD can be performed safely and dose-reducing without additional test bolus or bolus tracking scan. With very good image quality, it provides a detailed insight into the cardiac anatomy and thus enables a differentiated, noninvasive therapy planning.Copyright © 2019 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

19 keywords...

hide…